Abbott Laboratories (Abbott) is engaged in discovery, development, manufacture, and sale of diversified line of healthcare products. The Company operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Pharmaceutical Products include a line of adult and pediatric pharmaceuticals manufactured, marketed, and sold. Its Diagnostic Product...s include a line of diagnostic systems and tests manufactured, marketed, and sold to blood banks, hospitals, commercial laboratories, clinics, physicians' offices, alternate-care testing sites and plasma protein therapeutic companies. The Company’s Nutritional Products include a line of pediatric and adult nutritional products manufactured, marketed, and sold worldwide. Its Vascular Products include a line of coronary, endovascular, and vessel closure devices for the treatment of vascular disease manufactured, marketed and sold worldwide. For the fiscal year ended 31 December 2010, Abbott Laboratories' revenues increased 14% to $35.17B. Net income decreased 19% to $4.63B. Revenues reflects higher sales from Nutritional Products, higher from Diagnostics products and an increase in sales from Vascular products. Net income was offset by an increase in research & development expenses and higher selling, general and administration expenses, increase in interest expense.